A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters (original) (raw)
Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433 ArticlePubMedCAS Google Scholar
Prinzmetal M, Bloomberg W (1935) Use of benzedrine for the treatment of narcolepsy. J Am Med Assoc 105:2051–2054 CAS Google Scholar
Olfson M, Marcus SC, Weissman MM, Jensen PS (2002) National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 41:514–521 ArticlePubMed Google Scholar
Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681–698 ArticlePubMedCAS Google Scholar
Martinsson L, Eksborg S (2004) Drugs for stroke recovery: the example of amphetamines. Drugs Aging 21:67–79 ArticlePubMedCAS Google Scholar
Kirshner N (1962) Uptake of catecholamines by a particulate fraction of the adrenal medulla. J Biol Chem 237:2311–2317 PubMedCAS Google Scholar
Carlsson A, Hillarp NA, Waldeck B (1962) A Mg-ATP dependent storage mechanism in the amine granules of the adrenal medulla. Med Exp Int J Exp Med 6:47–53 PubMedCAS Google Scholar
Fon EA et al (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271–1283 ArticlePubMedCAS Google Scholar
Burn JH, Rand MJ (1958) The action of sympathomimetic amines in animals treated with reserpine. J Physiol 144:314–336 PubMedCAS Google Scholar
Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979–1986 PubMedCAS Google Scholar
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223 ArticlePubMedCAS Google Scholar
Sulzer D et al (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102–4108 PubMedCAS Google Scholar
Axelrod J (1965) The metabolism, storage, and release of catecholamines. Recent Prog Horm Res 21:597–622 PubMedCAS Google Scholar
Forrest L et al (2008) Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci USA 105:10338–10343 ArticlePubMedCAS Google Scholar
Erreger K, Grewer C, Javitch JA, Galli A (2008) Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci 28:976–989 ArticlePubMedCAS Google Scholar
Shi L, Quick M, Zhao Y, Weinstein H, Javitch JA (2008) The mechanism of a neurotransmitter:sodium symporter—inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol Cell 30:667–677 ArticlePubMedCAS Google Scholar
Yamashita A, Singh SK, Kawate T, Jin Y, Gouaux E (2005) Crystal structure of a bacterial homologue of Na+/Cl-dependent neurotransmitter transporters. Nature 437:215–223 ArticlePubMedCAS Google Scholar
Bruss M, Hammermann R, Brimijoin S, Bonisch H (1995) Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem 270:9197–9201 ArticlePubMedCAS Google Scholar
Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211–227 ArticlePubMedCAS Google Scholar
Chen JG, Liu-Chen S, Rudnick G (1998) Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J Biol Chem 273:12675–12681 ArticlePubMedCAS Google Scholar
Androutsellis-Theotokis A, Rudnick G (2002) Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci 22:8370–8378 PubMedCAS Google Scholar
Granas C, Ferrer J, Loland CJ, Javitch JA, Gether U (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J Biol Chem 278:4990–5000 ArticlePubMedCAS Google Scholar
Khoshbouei H et al (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2:E78 ArticlePubMed Google Scholar
Fog JU et al (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51:417–429 ArticlePubMedCAS Google Scholar
Li LB et al (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 279:21012–21020 ArticlePubMedCAS Google Scholar
Schenk JO (2002) The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate. Prog Drug Res 59:111–131 PubMedCAS Google Scholar
Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639–677 ArticlePubMedCAS Google Scholar
Raiteri M, Cerrito F, Cervoni AM, Levi G (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208:195–202 PubMedCAS Google Scholar
Heikkila RE, Orlansky H, Mytilineou C, Cohen G (1975) Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J Pharmacol Exp Ther 194:47–56 PubMedCAS Google Scholar
Parker EM, Cubeddu LX (1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245:199–210 PubMedCAS Google Scholar
Fischer JF, Cho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203–209 PubMedCAS Google Scholar
Burnette WB et al (1996) Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. Anal Chem 68:2932–2938 ArticlePubMedCAS Google Scholar
Zaczek R, Culp S, De Souza EB (1991) Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. J Pharmacol Exp Ther 257:830–835 PubMedCAS Google Scholar
Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960–974 PubMedCAS Google Scholar
Sitte HH et al (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289–1297 ArticlePubMedCAS Google Scholar
Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem 278:12070–12077 ArticlePubMedCAS Google Scholar
Pifl C, Singer EA (1999) Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol Pharmacol 56:1047–1054 PubMedCAS Google Scholar
Pifl C, Rebernik P, Kattinger A, Reither H (2004) Zn(2+) modulates currents generated by the dopamine transporter: parallel effects on amphetamine-induced charge transfer and release. Neuropharmacology 46:223–231 ArticlePubMedCAS Google Scholar
Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47:368–373 PubMedCAS Google Scholar
Pifl C, Agneter E, Drobny H, Reither H, Singer EA (1997) Induction by low Na+ or Cl− of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters. Br J Pharmacol 121:205–212 ArticlePubMedCAS Google Scholar
Seidel S et al (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol 67:140–151 PubMedCAS Google Scholar
Kahlig KM et al (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 102:3495–3500 ArticlePubMedCAS Google Scholar
Melikian HE, Buckley KM (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19:7699–7710 PubMedCAS Google Scholar
Loder MK, Melikian HE (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168–22174 ArticlePubMedCAS Google Scholar
Giambalvo CT (1992) Protein kinase C and dopamine transport-2. Effects of amphetamine in vitro. Neuropharmacology 31:1211–1222 CAS Google Scholar
Kantor L, Gnegy ME (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592–598 PubMedCAS Google Scholar
Cowell RM, Kantor L, Hewlett GH, Frey KA, Gnegy ME (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur J Pharmacol 389:59–65 ArticlePubMedCAS Google Scholar
Kantor L et al (2001) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J Pharmacol Exp Ther 297:1016–1024 PubMedCAS Google Scholar
Kantor L, Zhang M, Guptaroy B, Park YH, Gnegy ME (2004) Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells. J Pharmacol Exp Ther 311:1044–1051 ArticlePubMedCAS Google Scholar
Gnegy ME et al (2004) Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Mol Pharmacol 66:137–143 ArticlePubMedCAS Google Scholar
Johnson LA, Guptaroy B, Lund D, Shamban S, Gnegy ME (2005) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J Biol Chem 280:10914–10919 ArticlePubMedCAS Google Scholar
Foster JD, Pananusorn B, Vaughan RA (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J Biol Chem 277:25178–25186 ArticlePubMedCAS Google Scholar
Kantor L, Hewlett GH, Gnegy ME (1999) Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J Neurosci 19:3801–3808 PubMedCAS Google Scholar
Pierce RC, Kalivas PW (1997) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254–3261 PubMedCAS Google Scholar
Binda F et al (2008) Syntaxin1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol 74:1101–1108 ArticlePubMedCAS Google Scholar
Dipace C, Sung U, Binda F, Blakely RD, Galli A (2007) Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol Pharmacol 71:230–239 ArticlePubMedCAS Google Scholar
Sung U et al (2003) A regulated interaction of syntaxin 1A with the antidepressant- sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci 23:1697–709 PubMedCAS Google Scholar
Carvelli L, Blakely RD, DeFelice LJ (2008) Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci USA 105:14192–14197 ArticlePubMedCAS Google Scholar
Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834–838 PubMedCAS Google Scholar
Saunders C et al (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850–6855 ArticlePubMedCAS Google Scholar
Kahlig KM, Galli A (2003) Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol 479:153–158 ArticlePubMedCAS Google Scholar
Kahlig KM, Javitch JA, Galli A (2004) Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J Biol Chem 279:8966–8975 ArticlePubMedCAS Google Scholar
Kahlig KM et al (2006) Regulation of dopamine transporter trafficking by intracellular amphetamine. Mol Pharmacol 70:542–548 ArticlePubMedCAS Google Scholar
Chi L, Reith ME (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J Pharmacol Exp Ther 307:729–736 ArticlePubMedCAS Google Scholar
Gulley JM, Doolen S, Zahniser NR (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83:400–411 ArticlePubMedCAS Google Scholar
Owens WA et al (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem 94:1402–1410 ArticlePubMedCAS Google Scholar
Williams JM et al (2007) Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 5:2369–2378 ArticleCAS Google Scholar
Johnson LA, Furman CA, Zhang M, Guptaroy B, Gnegy ME (2005) Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49:750–758 ArticlePubMedCAS Google Scholar
Pristupa ZB et al (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30:79–87 ArticlePubMedCAS Google Scholar
Daniels GM, Amara SG (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794–35801 ArticlePubMedCAS Google Scholar
Sorkina T, Doolen S, Galperin E, Zahniser NR, Sorkin A (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J Biol Chem 278:28274–28283 ArticlePubMedCAS Google Scholar
Cervinski MA, Foster JD, Vaughan RA (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and down regulation by cocaine sensitive and protein kinase C dependent mechanisms. J Biol Chem 280:40442–40449 ArticlePubMedCAS Google Scholar
Boudanova E, Navaroli DM, Stevens Z, Melikian HE (2008) Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol Cell Neurosci 39:211–217 ArticlePubMedCAS Google Scholar
Boudanova E, Navaroli DM, Melikian HE (2008) Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54:605–612 ArticlePubMedCAS Google Scholar
Foster JD, Adkins SD, Lever JR, Vaughan RA (2008) Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem 105:1683–1699 ArticlePubMedCAS Google Scholar
Wei Y et al (2007) Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol 71:835–842 ArticlePubMedCAS Google Scholar
Chu PC, Lin MT, Shian LR, Leu SY (1986) Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes 35:481–485 ArticlePubMedCAS Google Scholar
Saitoh A, Morita K, Sodeyama M, Kamei J (1998) Effects of the experimental diabetes on dopamine D1 receptor-mediated locomotor-enhancing activity in mice. Pharmacol Biochem Behav 60:161–166 ArticlePubMedCAS Google Scholar
Karkanias GB, Morales JC, Li CS (1997) Deficits in reproductive behavior in diabetic female rats are due to hypoinsulinemia rather than hyperglycemia. Horm Behav 32:19–29 ArticlePubMedCAS Google Scholar
Doolen S, Zahniser NR (2001) Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther 296:931–938 PubMedCAS Google Scholar
Garcia BG et al (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68:102–109 PubMedCAS Google Scholar
Galici R et al (2003) Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77:132–140 ArticlePubMedCAS Google Scholar
Lute BJ et al (2008) PI3K signaling supports amphetamine-induced dopamine efflux. Biochem Biophys Res Commun 372:656–661 ArticlePubMedCAS Google Scholar
Zhu MY, Shamburger S, Li J, Ordway GA (2000) Regulation of the human norepinephrine transporter by cocaine and amphetamine. J Pharmacol Exp Ther 295:951–959 PubMedCAS Google Scholar
Jayanthi LD, Annamalai B, Samuvel DJ, Gether U, Ramamoorthy S (2006) Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. J Biol Chem 281:23326–23340 ArticlePubMedCAS Google Scholar
Jayanthi LD, Samuvel DJ, Ramamoorthy S (2004) Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. evidence for localization in lipid rafts and lipid raft-mediated internalization. J Biol Chem 279:19315–19326 ArticlePubMedCAS Google Scholar
Mazei-Robison MS et al (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28:7040–7046 ArticlePubMedCAS Google Scholar